NLRP3 and stroke disorder: Idebenone, a mitochondrial protectant, has suppressed NLRP3 inflammation by mitigating mitochondrial dysfunction induced by cerebral ischemia/stroke and microglia overactivation to alleviate infarct volume and neurological deficit (Peng et al., 2020).